Mylan Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens.

Medication SafetyEducators and caregiversHealthcare Professional

Jul 8

Written By Denise Kolakowski

Learn more from the FDA

Denise Kolakowski

MDHHS recommends Michiganders to avoid foam on waterbodies

Infant Formula Information and Ongoing FDA Efforts to Increase Supply